logo-loader
viewCallitas Health Inc.

M Pharma's Gary Thompson 'excited' to receive US Extrinsa trademark

Gary Thompson, president and chief executive of M Pharmaceutical Inc (CSNX:MQ, OTCMKTS:MPHMF) tells Proactive they've received an official trademark for Extrinsa from the US patent office.

The treatment is a solution for female sexual dysfunction (FSD).

Quick facts: Callitas Health Inc.

Price: 0.11 CAD

CSE:LILY
Market: CSE
Market Cap: $3.62 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Callitas Health Inc. named herein, including the promotion by the Company of Callitas Health Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Callitas Therapeutics signs LOI with Simply Wholeistic, updates on THC & CBD...

Callitas Therapeutics (CSE:LILY) (OTCQB:MPHMF) Vice President of Sales & Business Development Joshua Maurice tells Proactive Investors the pharma company has signed a letter of intent with Simply Wholeistic to manufacture  its CannaStrip products in the U.S. Maurice added that as...

on 04/25/2019

2 min read